Tecfidera
Brand for: Dimethyl fumarate
My Prescription
Payment
Select pharmacy
$44.00
Print or send this coupon to your phone
AlbertsonsPowered byAbout Tecfidera
Drug Details
Dimethyl fumarate, also known by the brand name Tecfidera, is prescribed for adults with relapsing forms of multiple sclerosis (MS), a disease that affects the nervous system. While not a cure, it helps reduce the frequency of MS relapses. This medication is a disease-modifying therapy (DMT) and is classified as a fumaric acid derivative. It is available both as a brand-name and a more affordable generic option. The medication is taken orally in capsule form, twice a day. Common side effects may include stomach discomfort and flushing, which can manifest as warmth, redness, or a burning sensation in the face. Always consult with your healthcare provider before starting any new medication to ensure it is appropriate and safe for your condition.
Tecfidera (Dimethyl Fumarate) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 120MG | 14 Capsule Delayed Releases | $22.34 | $1.60 |
| 240MG | 60 Capsule Delayed Releases | $44.20 | $0.74 |
| 240MG | 90 Capsule Delayed Releases | $57.81 | $0.64 |
| 240MG | 180 Capsule Delayed Releases | $98.61 | $0.55 |
Tecfidera FAQs
Tecfidera is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps to reduce the frequency of flare-ups and slow the progression of physical disability associated with MS.
Tecfidera is not being discontinued. There may be confusion due to patent issues or market competition, but the medication continues to be available for patients with multiple sclerosis. If there are specific concerns about availability, it is advisable to consult a healthcare provider or pharmacist for the most current information.
Tecfidera (dimethyl fumarate) is considered an effective treatment for relapsing forms of multiple sclerosis (MS). Clinical trials have shown that it can reduce the frequency of relapses and slow the progression of disability. It also has been shown to decrease the number of new or enlarging brain lesions as seen on MRI. However, the effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to determine if Tecfidera is the right treatment option for their specific condition.
Yes, Tecfidera (dimethyl fumarate) is considered to have immunomodulatory effects, which means it can alter the immune system's response. While it is not classified strictly as an immunosuppressant, it does have the ability to reduce the activity of the immune system, which can help in managing multiple sclerosis.
Dimethyl fumarate is primarily used to treat multiple sclerosis. It works by modulating the immune system to reduce inflammation and prevent immune cells from attacking the nervous system. This helps decrease the frequency of relapses and slows the progression of physical disability in patients with multiple sclerosis. Additionally, it has antioxidant properties that may protect nerve cells from damage.